Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
The Most Astonishing Arising Advances to Watch - 2From Dread to Certainty: Individual Accounts of Strengthening
- 3NASA’s history-making moon mission aims to send the first woman and person of color to deep space
- 4Lucrative Positions in the Advancing Position Market of 2024
- 5New hybrid mpox strain discovered in UK after US reports local spread
- Elite Execution Wall televisions for Film Darlings
- Zendaya serves bridal-coded fashion with old, new and borrowed gowns for ‘The Drama’ press tour
- Islamabad: Iran allows 20 Pakistani ships through Strait of Hormuz
- Vote In favor of Your Favored Occasion Arranging Administration
- IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- NATO official says members often aren't buying weapons together, and it's a mistake
- Palestinian leader Abbas says elections only after Gaza war ends
- A hunger for new experiences Narratives: Motivating Travel and Experience
- Jamie Dimon warns Iran war could drive inflation, interest rates higher
